News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
May 9, 2025, 09:22

Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Intracytoplasmic inclusions observed by histopathology in corneal epithelium of patients exposed to belantamab mafodotin show corneal change pattern suggesting limbal vessels may be primary pathway enabling ADC to reach cornea.”

Title: Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma

Authors: Vivian Lee, Malin Hultcrantz, Stephanie Petrone, Eric W. Lewis, Hussam Banna, Eben Lichtman, Praneetha Thulasi, Anjulie A. Quick, Bennie H. Jeng, Sarah B. Sunshine, Jasmine H. Francis, Julia Canestraro, Asim V. Farooq, Peter Clements, Nicola Robertson, Mark Burman, Tom McKevitt, Herbert Struemper, Lucinda Weir

Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski

Read the Full Article in JAMA Ophthalmology.

More posts featuring Robert Orlowski.

Anjulie A. Quick Asim V. Farooq Bennie H. Jeng cancer Eben Lichtman Eric W. Lewis Herbert Struemper Hussam Banna JAMA Ophthalmology Jasmine H. Francis Julia Canestraro Lucinda Weir Malin Hultcrantz Mark Burman multiple myeloma Myeloma Paper of the Day Nicola Robertson OncoDaily Oncology Peter Clements Praneetha Thulasi Robert Orlowski Sarah B. Sunshine Stephanie Petrone Tom McKevitt Vivian Lee
Special Coverage
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients
Career
May 9, 2025, 07:02
Vinay Prasad Appointed as the New Head of FDA's Center for Biologics Evaluation and Research
Blog
May 9, 2025, 06:47
Wade Swenson: Addressing the rural cancer care crisis in Minnesota requires innovative solutions
Oncolibrary
May 9, 2025, 06:27
Understanding Neoplasms: What They Are, Types, Causes, and How They’re Treated